Clinical trial · no report yet · Phase 3
CARE1
CARE1 Pragmatic Clinical Trial
- NCT06364631 ↗
- Recruiting
- Gustave Roussy, Cancer Campus, Grand Paris
- Deep
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 24 | |
| YouTube | 9 | |
| Podcasts | 5 | |
| Bluesky threads | 1 | |
| X videos | 1 |
The trial
ClinicalTrials.gov- Official title
- First Line Randomised Study Platform to Optimize Treatment in Patients With Metastatic Renal Cell Carcinoma
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Metastatic Kidney Cancer; Metastatic Kidney Carcinoma
- Interventions
- Nivolumab; Ipilimumab; Pembrolizumab; Cabozantinib; Axitinib; Lenvatinib
- Arms
- Arm A: ICI - ICI Combination · Other
- Arm B: VEGFR-TKI- ICI arm (axitinib + pembrolizumab) · Other
- Enrollment
- 1,250 (estimated)
- Primary outcomes
- Overall Survival (OS).
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris with European Commission, CRIS Cancer Foundation, National Cancer Institute, France, Rennes University Hospital, University Hospital, Essen, Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron, The Netherlands Cancer Institute, Servicio Madrileño de Salud, Madrid, Spain, Hospital Universitario 12 de Octubre, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Medical University of Vienna, FAKULTNI NEMOCNICE OLOMOUC, International Kidney Cancer Coalition, Association pour la Recherche sur les Tumeurs du Rein, Resilience, PRIMAA, Queen Mary University of London
- Start
- Apr 12, 2024
- Primary completion
- May 5, 2032 (estimated)
- Results posted
- No
- Registry record
- NCT06364631 · updated Jan 16, 2025